{
  "abstract": "Gastrointestinal (GI) adverse events, such as nausea, vomiting, diarrhea, and constipation, remain a dominant barrier to the sustained use of GLP-1 receptor agonists (GLP-1 RAs), driving discontinuation independently of the drug's metabolic benefits. Two host-side biological systems have been independently established as determinants of this variability. The first is host genetics, anchored by a 2026 genome-wide association study in which GLP1R variants predicted both weight-loss efficacy and nausea or vomiting risk, while a GIPR signal for vomiting was restricted to tirzepatide users. The second system is the gut microbiome, which regulates endogenous GLP-1 secretion through short-chain fatty acid and bile acid signaling and is itself reshaped by GLP-1 RA exposure. Pharmacomicrobiomics integrates host genetic and microbiome data to explain drug response. In the literature surveyed for this review, these two determinants are consistently examined in parallel rather than jointly: we did not identify a study, in GLP-1 RA therapy or in another drug class, that fit a 'host-genotype-by-microbiome' interaction model against a drug tolerability outcome. Published methodological studies have suggested why such a study would be challenging: both interaction detection and the measurement unreliability associated with single-timepoint microbiome profiling impose substantial sample size penalties. This review summarizes what host genetics and the microbiome individually do and do not explain about GLP-1 RA tolerability, and describes the study design features, paired genotyping, repeat-sample metagenomics, and prospective symptom capture that a future joint analysis would require.",
  "abstract_shown": true,
  "affiliations": [
    "Digbi Health, Mountain View, CA, United States."
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Shreyas V Kumbhare"
    },
    {
      "affs": [
        0
      ],
      "name": "Inti Pedroso"
    },
    {
      "affs": [
        0
      ],
      "name": "Ranjan Sinha"
    },
    {
      "affs": [
        0
      ],
      "name": "Daniel E Almonacid"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dz94ccqegd1xa.bib",
  "cited_by": 0,
  "doi": "10.3389/frmbi.2026.2016564",
  "fulltext_url": "https://europepmc.org/articles/PMC13749394",
  "id": "dz94ccqegd1xa",
  "issns": [
    "2813-4338"
  ],
  "landing_url": "https://europepmc.org/article/MED/43011784",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Mini Review"
    ],
    [
      "openalex",
      "1312|Gut microbiota and health"
    ]
  ],
  "openalex": "W7223975381",
  "pdf_url": "https://europepmc.org/articles/PMC13749394?pdf=render",
  "pmcid": "PMC13749394",
  "pmid": "43011784",
  "published": "2026-10-27",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/dz94ccqegd1xa.ris",
  "sources": [
    {
      "first_seen": "2026-11-12T15:25:13Z",
      "native_id": "MED:43011784",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/43011784"
    },
    {
      "first_seen": "2026-11-14T12:22:11Z",
      "native_id": "PMC13749394",
      "source": "pmc",
      "url": "https://doi.org/10.3389/frmbi.2026.2016564"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "openalex:1312|Gut microbiota and health",
      "subfield": "molecular-biology"
    }
  ],
  "title": "Pharmacomicrobiomics of GLP-1 receptor agonist gastrointestinal tolerability: integrating host genetics and the gut microbiome.",
  "title_text": "Pharmacomicrobiomics of GLP-1 receptor agonist gastrointestinal tolerability: integrating host genetics and the gut microbiome.",
  "type": "peer-reviewed",
  "updated_at": "2026-11-14T12:22:11Z",
  "url": "https://research.draconitic.com/paper/dz94ccqegd1xa",
  "venue": "Frontiers in microbiomes",
  "versions": []
}